Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
SBC Medical Group Holdings Incorporated(SBC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SBC
10/09/2026: SBC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
SBC Medical Group Holdings provides critical management, branding, and operational support to aesthetic medical clinics, primarily in Japan. The company benefits from a scalable business model that leverages the Shonan Beauty Clinic brand to maintain a significant presence in the aesthetic services market. Its growth strategy revolves around expanding this clinic network and potentially entering international markets. However, investors must consider risks including geographic concentration in Japan, dependence on discretionary consumer spending, and the evolving regulatory environment for medical services. The stock may best suit growth-oriented investors who are comfortable with the inherent volatility of the aesthetic healthcare sector and who will monitor the success of planned international expansions.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company's model for scaling aesthetic management services offers exposure to the growing demand for cosmetic procedures. |
| Momentum investor | Mixed fit | Momentum appeal is conditional on consistent positive earnings growth and expansion signals in the Japanese market. |
| Value investor | Mixed fit | Valuation fit depends on the company's ability to maintain high margins as it scales its support infrastructure. |
| Dividend investor | Weak fit | The company is currently prioritizing capital allocation toward growth rather than consistent dividend distributions. |
| Low-risk investor | Weak fit | Exposure to the discretionary aesthetic market and regulatory landscape introduces higher volatility profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Small-cap aesthetic service companies often experience significant price swings based on sentiment. |
| Valuation risk | Medium | Investors must assess whether current valuations account for long-term growth limitations. |
| Competition risk (aesthetic clinics) | Medium | The sector is increasingly competitive, requiring constant brand reinvestment. |
| Business quality | Medium | Profitability is tied to the efficiency of the clinic management model. |
| Dividend income | Low / none | Income investors should not expect significant yield in the near term. |
| Execution risk | Medium | Failure to expand or maintain support quality could impact revenue streams. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 38.35% | Avg. Invested days 55 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 557.43M USD | Price to earnings Ratio 11.29 | 1Y Target Price 8.75 |
Price to earnings Ratio 11.29 | 1Y Target Price 8.75 | ||
Volume (30-day avg) 210.4K shares | Beta 0.55 | 52 Weeks Range 2.78 - 5.51 | Updated Date 10/10/2026 |
52 Weeks Range 2.78 - 5.51 | Updated Date 10/10/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.48 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Management Support Services | Fees collected from clinics for branding, marketing, and operational consulting. | The company acts as the backbone for aesthetic clinics, earning money by helping them run more efficiently. |
| Geography (Japan) | All revenues currently derived from the Japanese market. | Performance is highly sensitive to the Japanese economic climate and domestic consumer trends. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 11.29 | Forward PE 9.33 | Enterprise Value 362.42M | Price to Sales(TTM) 3.18 |
Enterprise Value 362.42M | Price to Sales(TTM) 3.18 | ||
Enterprise Value to Revenue 2.07 | Enterprise Value to EBITDA 4.58 | Shares Outstanding 102.85M | Shares Floating 18.11M |
Shares Outstanding 102.85M | Shares Floating 18.11M | ||
Percent Insiders 81.53 | Percent Institutions 4.45 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.